Some S100 members (e.g., S100A4, S100A8/A9, S100A12 and S100B) have also been suggested to represent potential biomarkers of NAFLD-associated disorders such as obesity, type 2 diabetes, IR and inflammation [36,38]. This evidence concerns the gene S100A1 and metabolic dysfunction-associated steatotic liver disease.